Invention Grant
- Patent Title: Fixed drug ratios for treatment of hematopoietic cancers and proliferative disorders
- Patent Title (中): 用于治疗造血癌和增殖性疾病的固定药物比例
-
Application No.: US12032583Application Date: 2008-02-15
-
Publication No.: US08092828B2Publication Date: 2012-01-10
- Inventor: Arthur Louie , Christine Swenson , Lawrence Mayer , Andrew Janoff
- Applicant: Arthur Louie , Christine Swenson , Lawrence Mayer , Andrew Janoff
- Applicant Address: US NJ Princeton
- Assignee: Celator Pharmaceuticals, Inc.
- Current Assignee: Celator Pharmaceuticals, Inc.
- Current Assignee Address: US NJ Princeton
- Agency: Morrison & Foerster LLP
- Main IPC: A61K9/127
- IPC: A61K9/127 ; A61K31/00
Abstract:
Provided herein are methods for treating cancer by administering a pharmaceutical composition comprising a fixed, non-antagonistic molar ratio of cytarabine and an anthracycline. Such methods are particularly useful in the treatment of patients with advanced hematologic cancers or proliferative disorders.
Public/Granted literature
- US20080199515A1 FIXED DRUG RATIOS FOR TREATMENT OF HEMATOPOIETIC CANCERS AND PROLIFERATIVE DISORDERS Public/Granted day:2008-08-21
Information query
